Category: Prostate Cancer Detection

A new paper on PSA screening for prostate cancer (PCa) begins by pointing out that screening reduces PCa deaths; however, PSA followed by immediate biopsy increases cases of low-risk patients who have overly aggressive treatments that leave them with impaired urinary or sexual function—up to 12 years or more![i] The authors propose more refined screening keep reading

In the world of prostate cancer (PCa), there is a dangerous cell pattern called cribriform (pronounced crib’ ri-form) or simply Cr. It has a distinctive appearance that looks similar to a sieve or a plate with lots of holes. Cr is associated with aggressive Gleason grade 4 cancer. Also, there is another PCa type called keep reading

It’s not exactly the ultimate “American Dream” but it’s great news for clarifying a suspicious PSA test result. As we know, the PSA blood test is controversial as a screening tool for prostate cancer (PCa) because an unexpectedly high result can mean any number of things, not just PCa. And yet, on the chance that keep reading

If you’ve ever been involved in a simulation game, or a simulation training model, you are interacting with something that’s not really there but feels like it is. In fact, during the experience the same neurons in the brain are activated as if the simulation IS the real world. Thus, the brain can be functionally keep reading

A groundbreaking European study highlights the benefits of adding MRI to PSA screening for prostate cancer. By improving detection of significant cancers and reducing unnecessary biopsies, this approach offers a more accurate, cost-effective pathway for diagnosis. Discover how this research is transforming prostate health and diagnosis standards worldwide. keep reading

Want to avoid a biopsy after an abnormal PSA test? A new study shows that a negative multiparametric MRI might just be your ticket. Learn how MRI scans are reducing unnecessary biopsies and pinpointing significant prostate cancer with precision. keep reading

Multiparametric MRI (mpMRI) has proven itself as a powerful tool in detecting significant prostate cancer. By accurately identifying suspicious areas and distinguishing aggressive tumors from those that pose less risk, mpMRI is helping reduce unnecessary biopsies and providing clearer, more reliable diagnostic information for better treatment decisions. keep reading

Researchers are advancing smarter prostate cancer screening methods. A new biomarker test, combined with advanced MRI techniques, could improve early detection of high-grade prostate cancers and reduce the need for unnecessary procedures, offering more accurate and reliable diagnosis. keep reading

Combining multiparametric MRI with genomic testing is revolutionizing prostate cancer detection and treatment. By leveraging the strengths of both technologies, doctors can achieve more accurate diagnoses, guide personalized treatment decisions, and improve patient outcomes. Learn how these tools are shaping the future of prostate cancer care. keep reading

Based on the standard five-letter grading system (A, B, C, D, F), getting your report card may or may not have been a time of dread. However, that system did not raise every kid’s anxiety until its universal adoption by U.S. schools in the 1940s. Were you ever curious as to why the letter E keep reading